ARTICLE | Clinical News
BioChem regulatory update
July 3, 1995 7:00 AM UTC
Partner Glaxo Wellcome Inc. completed the submission of an NDA for 3TC (lamivudine) to treat AIDS in combination with AZT. The FDA will review the application under its accelerated approval regulati...